Boston, MA and Elm Grove, IL – QMENTA and Imaging Biometrics (IB) join forces to accelerate neuroscience research and increase accuracy in diagnostics support for clinical applications in neurology such as brain tumours and stroke. Imaging Biometrics will integrate all IB modules: IB Neuro and IB Diffusion, both FDA cleared products for clinical care in patients suffering from brain tumors, stroke, and other neurological disorders, along with IB Delta T1 Maps and IB DCE on the cloud-based QMENTA platform.
This allows IB’s modules to run on QMENTA system, allowing professionals – neurologists, neuroradiologists, medical experts – fast and easy access to these advanced algorithms in a secure environment. The combination of the powerful FDA cleared tools of Imaging Biometrics and QMENTA’s HIPAA, FDA and GDPR compliant platform will be a key decision point for use of any neurologist and radiologist who wants to give the best care for their patients.
Imaging Biometrics’ CEO, Michael Schmainda says:
“Our partnership with QMENTA enables efficient and immediate access to our quantitative imaging solutions to those involved in clinical trials and research. It is exciting to be part of QMENTA’s neuro-centric platform and helping advance the understanding of neurological disorders.”
QMENTA’s CEO, Paulo adds:
“We are very excited of this new partnership as we will be increasing our offerings with FDA cleared tools for clinical applications such as stroke and tumors as well as our first algorithms in PET imaging. This partnership will enable us to provide additional service for our customers by allowing them to clinically use the QMENTA platform knowing they can trust and rely on powerful and efficient tools such as the ones that Imaging Biometrics is developing. ”
About the partners
Imaging Biometrics, a subsidiary of Flying Brands Limited (LON:FBDU), develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with top researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB’s advanced visualization software seamlessly integrates into routine workflows. For more information about Imaging Biometrics, visit the company’s website at www.imagingbiometrics.com.
QMENTA offers a cloud-based platform to streamline the medical imaging workflow for running clinical trials. QMENTA’s aim is to accelerate the discovery and development of new treatments for neurological diseases using state-of-the-art image processing techniques in a seamless way. QMENTA is currently launching a Software Development Kit (SDK) that offers B2B partnerships with other imaging solutions in the market, making the platform standardized distribution space in the medical image processing market by providing cloud-based, compliant and powerful environment.
QMENTA has been growing since 2013 in EU & US, now supporting many multi-center studies and a number of clinical trials. The company was named “Best New Radiology Vendor” in 2017 by Aunt Minnie and was a European Winner for Accenture’s Healthtech Innovation Challenge and won the Sanofi Tech Lab challenge. For more information on the company, visit www.qmenta.com.
Follow QMENTA on social media:
Follow Imaging Biometrics on social media:
Linkedin Imaging Biometrics LLC